Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Nov 2025 for ARS Pharmaceuticals, Inc., €12k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Brian Dorsey: trading record in brief
All filings by Brian Dorsey on record concern ARS Pharmaceuticals, Inc. Over a trading history stretching from 13 August 2024 to 13 November 2025, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 14 November 2025, the filings show an option exercise worth €12k in ARS Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brian Dorsey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
21,828 shares@ US$0.6417.9% of flowCommon StockSEC:0001380762-25-000005:0
15,000 shares@ US$0.6413.5% of flowCommon StockSEC:0001415889-24-029376:0
50,000 shares@ US$0.6442.7% of flowCommon StockSEC:0001415889-24-021886:0
30,000 shares@ US$0.6425.9% of flowCommon StockSEC:0001415889-24-021364:0
4 of 4 declarations
